Early Phase 1 Hypertension Trial, Recruiting (NCT04532489)

Early Phase 1 Hypertension Trial, Recruiting NCT04532489 Sponsor: Benjamin Viglianti Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT04532489 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have no known problems or diseases affecting their adrenal glands (small glands located above the kidneys), who would participate as healthy comparison subjects to help measure radiation levels from imaging

Who may not be able to join:

People who are pregnant
People who are unable to undergo medical imaging scans
People who weigh more than 400 pounds (181 kilograms)
People who are currently incarcerated (in prison)
People who are not able to give their own consent to participate in the trial
People who are currently taking steroids, the contraceptive pill, spironolactone, estrogen, androgen, progesterone, blood pressure medications known as ACE inhibitors or ARBs, or any supplements that act like hormones in the body
People who have any known condition or disease affecting their adrenal glands

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Ben Viglianti, M.D, Ph.D., University of Michigan

Phone: 734-615-7391

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04532489

Sponsor: Benjamin Viglianti

Phase: Early Phase 1

Status: Recruiting

Condition: Hypertension

Trial contact: 734-615-7391

More information: https://clinicaltrials.gov/study/NCT04532489

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have no known problems or diseases affecting their adrenal glands (small glands located above the kidneys), who would participate as healthy comparison subjects to help measure radiation levels from imaging

Who may not be able to join:

People who are pregnant
People who are unable to undergo medical imaging scans
People who weigh more than 400 pounds (181 kilograms)
People who are currently incarcerated (in prison)
People who are not able to give their own consent to participate in the trial
People who are currently taking steroids, the contraceptive pill, spironolactone, estrogen, androgen, progesterone, blood pressure medications known as ACE inhibitors or ARBs, or any supplements that act like hormones in the body
People who have any known condition or disease affecting their adrenal glands

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

Benjamin Viglianti

Registry

ClinicalTrials.gov

Start date

18 January 2021

Est. completion

1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Uptake for [18F]FNP-59 in the adrenal glands using the standardized uptake value (SUV) based on gland segmentation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov